Showing results (551-560 of 701) with videos related to
Sort By:
Pageof 71
Diabetes Care|September 23, 2022
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Melanie J Davies, Vanita R Aroda, Billy S Collins, et al.Journal of General Internal Medicine|December 15, 2023
Effects of Dapagliflozin in Chronic Kidney Disease Across the Spectrum of Age and by SexMargaret K Yu, Priya Vart, Niels Jongs, et al.European Journal of Preventive Cardiology|June 27, 2017
Epicardial, pericardial and total cardiac fat and cardiovascular disease in type 2 diabetic patients with elevated urinary albumin excretion rateRegitse H Christensen, Bernt J von Scholten, Christian S Hansen, et al.Kidney International Reports|March 8, 2022
The Kidney Protective Effects of the Sodium-Glucose Cotransporter-2 Inhibitor, Dapagliflozin, Are Present in Patients With CKD Treated With Mineralocorticoid Receptor AntagonistsMichele Provenzano, Niels Jongs, Priya Vart, et al.JAMA|September 2, 2015
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical TrialGeorge L Bakris, Rajiv Agarwal, Juliana C Chan, et al.Diabetes Technology & Therapeutics|October 24, 2024
Possible Glycemic Effects of Vagus Nerve Stimulation Evaluated by Continuous Glucose Monitoring in People with Diabetes and Autonomic Neuropathy: A Randomized, Sham-Controlled TrialHuda Kufaishi, Davide Bertoli, Ditte Smed Kornum, et al.Journal of the American Society of Nephrology : JASN|August 17, 2022
Correlates and Consequences of an Acute Change in eGFR in Response to the SGLT2 Inhibitor Dapagliflozin in Patients with CKDNiels Jongs, Glenn M Chertow, Tom Greene, et al.Journal of the American College of Cardiology|January 6, 2026
Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both: Secondary Analysis of the CONFIDENCE Randomized TrialRajiv Agarwal, Jennifer B Green, Hiddo J L Heerspink, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 27, 2026
Sexual Dimorphism and Age Effects in CKD and Type 2 Diabetes in the CONFIDENCE TrialRajiv Agarwal, Jennifer B Green, Hiddo J L Heerspink, et al.International Urology and Nephrology|June 13, 2026
Abdominal waist circumference and subcutaneous adipose tissue thickness predicts development of post-transplant diabetes mellitusMehmet Kanbay, Feyyaz H Yagmur, Bilge Karadeniz, et al.Pageof 71